TGF-β has previously been shown to inhibit the expression of CCR7 on BMDCs [161], suggesting that a lack of chemokine guidance may explain the decreased capacity of DCs to reach the tumour-draining lymph node. The gene discussed is TGFB1; the disease is neoplasm.